Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
SRD5A1 is predominantly expressed in skin and annexes 23,25,26
After reviewing a wide range of reconstitution approaches, The Peptide Guide consistently finds that the most common dosing errors come from choosing volumes that produce concentrations too high to measure reliably on a standard syringe
Major medical organizations do not endorse growth hormone or its secretagogues for anti-aging
Injecting peptides rather than taking them orally is often preferred due to the possibility of them being degraded by the digestive system
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
US$ 29.27
US$ 21.43
US$ 27.66
US$ 20.11
US$ 25.91
US$ 24.43
US$ 20.41
